Genetic basis for activity differences between vancomycin and glycolipid derivatives of vancomycin.
about
Combinatorial biosynthesis of novel antibiotics related to daptomycinIdentification of two inner-membrane proteins required for the transport of lipopolysaccharide to the outer membrane of Escherichia coliMembrane integration of an essential β-barrel protein prerequires burial of an extracellular loop.Characterization of a stalled complex on the β-barrel assembly machine.bam Lipoproteins Assemble BamA in vitro.Disulfide rearrangement triggered by translocon assembly controls lipopolysaccharide exportGenetic, biochemical, and molecular characterization of the polypeptide transport-associated domain of Escherichia coli BamA.Assembly of the β-Barrel Outer Membrane Proteins in Gram-Negative Bacteria, Mitochondria, and Chloroplasts.The reconstituted Escherichia coli Bam complex catalyzes multiple rounds of β-barrel assembly.Lipoprotein LptE is required for the assembly of LptD by the beta-barrel assembly machine in the outer membrane of Escherichia coli.Dissection of β-barrel outer membrane protein assembly pathways through characterizing BamA POTRA 1 mutants of Escherichia coli.Reconstitution of outer membrane protein assembly from purified componentsBiogenesis of beta-barrel membrane proteins in bacteria and eukaryotes: evolutionary conservation and divergence.YfiO stabilizes the YaeT complex and is essential for outer membrane protein assembly in Escherichia coli.Strong decrease in invasive ability and outer membrane vesicle release in Crohn's disease-associated adherent-invasive Escherichia coli strain LF82 with the yfgL gene deleted.Genetically engineered lipopeptide antibiotics related to A54145 and daptomycin with improved properties.HtrA stress protein is involved in intramacrophagic replication of adherent and invasive Escherichia coli strain LF82 isolated from a patient with Crohn's diseaseCharacterization of six lipoproteins in the sigmaE regulon.How antibiotics kill bacteria: from targets to networksA novel membrane protein, VanJ, conferring resistance to teicoplanin.Powerful partners: Arabidopsis and chemical genomicsMoenomycin family antibiotics: chemical synthesis, biosynthesis, and biological activityThe bacterial cell wall as a source of antibacterial targets.Vancomycin resistance: small molecule approaches targeting the bacterial cell wall biosynthesis.Validation of inhibitors of an ABC transporter required to transport lipopolysaccharide to the cell surface in Escherichia coli.A mutant Escherichia coli that attaches peptidoglycan to lipopolysaccharide and displays cell wall on its surface.Vancomycin analogues active against vanA-resistant strains inhibit bacterial transglycosylase without binding substrate.Differential effects of yfgL mutation on Escherichia coli outer membrane proteins and lipopolysaccharide.Using Small Molecules to Dissect Non-apoptotic Programmed Cell Death: Necroptosis, Ferroptosis, and Pyroptosis.Importance of Real-Time Assays To Distinguish Multidrug Efflux Pump-Inhibiting and Outer Membrane-Destabilizing Activities in Escherichia coli.New advances in antibiotic development and discovery.Inhibition of virulence-promoting disulfide bond formation enzyme DsbB is blocked by mutating residues in two distinct regions.Advances in understanding bacterial outer-membrane biogenesis.Analysis of YfgL and YaeT interactions through bioinformatics, mutagenesis, and biochemistry.Special delivery: vesicle trafficking in prokaryotes.Outer membrane antigens of the uropathogen Proteus mirabilis recognized by the humoral response during experimental murine urinary tract infection.Cell shape and cell-wall organization in Gram-negative bacteriaLipopolysaccharide transport and assembly at the outer membrane: the PEZ modelMistranslation of membrane proteins and two-component system activation trigger antibiotic-mediated cell death.MzrA: a novel modulator of the EnvZ/OmpR two-component regulon
P2860
Q24676630-5DA29670-1858-490B-9631-BB6CC7A9FDF8Q28492667-79FC08AD-9424-426C-A413-D3EB26D0A3CEQ30152660-CCFBB2E2-9237-4111-AF1D-8754436D3DBCQ30152753-F10C2B3B-0C01-44D9-89DA-80A733AE125EQ30153542-9BE1DC91-F0F0-4C77-83E3-9B9BAC538B05Q30155243-F4114EB0-A07C-4CF1-A275-C80EA5F0FF45Q30155324-3C99BAF4-3F91-420B-8A23-ECFA1F79E52AQ30155403-03293C67-1683-4DBE-806F-76457FCDDE28Q30155497-1C540026-B7BE-459C-9D84-1435BF682816Q30155881-CC3E1F42-33E9-4836-9442-5734BA5BB762Q30156805-7B56C0CE-0830-4F53-B507-19D6A4357415Q30156906-D1770709-2BF5-418C-9AF0-27E2835AF448Q30157280-65BDC621-9C0A-4423-BBAB-04925BBCAE39Q30159740-0177A50B-3E44-4625-BC77-2E1E1D3557E1Q31154381-2216D59D-8615-4F76-8039-73DBE2DBE09EQ33768851-E68DD673-780F-478E-A370-963B86D7A0E6Q33793481-74C7B90D-8043-4038-9899-6529D993AA17Q33855793-5095E1BD-4E24-4D13-951B-87546BE0D095Q33958766-5F09FBDF-3F2E-43E4-BC76-7EDF318F29C9Q34122537-2AECCCCF-9C82-49A0-94A2-F06F54B25728Q34149856-7214526B-B775-4BC6-80E0-61352D5F754BQ34329962-CE3D8797-CC3C-42FD-943E-E38735D2FEACQ34568935-8173E756-F040-4138-83C9-94CB143481A3Q34587629-0397A38F-5EEC-47BD-BB56-2CDC90172857Q34715492-F2A48A6F-B3AE-4F1B-906F-DD19BA08A0CEQ34975937-E52E7F50-1969-4847-B41C-C9FD1CAB02D4Q35021822-A5B6CB13-D978-4A3D-89D6-36A64B6C3276Q35130101-7BEC2825-9599-4C83-A35F-25B92F84BD3FQ35781653-22AE21E9-60B7-4770-8532-5E6EB926D5AEQ35899824-956DF7B9-E990-4846-8F30-FCBC74DEA5D3Q36065983-A1DE4A59-D90F-4A5E-9834-4A10C69F5DDDQ36289066-94E06156-B290-4DBB-B576-8E920CE561BDQ36343565-1F50F179-F118-4FEA-84AF-626D961F3A9BQ36483177-80EAB28A-3827-4242-AC1F-FE598A9F5B30Q36552173-3A5ABAF3-47ED-46F3-B16B-3BBD9BA84C3CQ36845213-40D9EF61-0CBD-451B-9E2C-4A580BB6CAAEQ36993740-9200957A-5AD4-4354-BCB0-C75CB7C864AAQ37077552-ED852605-F972-400F-99FA-0BF2D74B0412Q37198083-C0682CFE-5B4A-43E4-98CE-7C78037B849BQ37306714-91965A53-4C52-4071-A905-33EE4DD26FE6
P2860
Genetic basis for activity differences between vancomycin and glycolipid derivatives of vancomycin.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Genetic basis for activity dif ...... pid derivatives of vancomycin.
@en
Genetic basis for activity dif ...... pid derivatives of vancomycin.
@nl
type
label
Genetic basis for activity dif ...... pid derivatives of vancomycin.
@en
Genetic basis for activity dif ...... pid derivatives of vancomycin.
@nl
prefLabel
Genetic basis for activity dif ...... pid derivatives of vancomycin.
@en
Genetic basis for activity dif ...... pid derivatives of vancomycin.
@nl
P2093
P50
P356
P1433
P1476
Genetic basis for activity dif ...... ipid derivatives of vancomycin
@en
P2093
A A Branstrom
R C Goldman
P304
P356
10.1126/SCIENCE.1063611
P407
P577
2001-08-23T00:00:00Z